Lauren Broffman, PhD’s Post

Get your free ticket now! Our clinical experts will show why a holistic approach to weight management is key to achieving sustainable health outcomes for weight loss. 

Excited to share my case report on Superior Mesenteric Artery Syndrome. Highlighting the challenges faced and the successful outcomes achieved. Stay tuned for more insights into this interesting medical condition! #MedicalCaseStudy #SuperiorMesentericArterySyndrome #Healthcare

A quick search online reveals that, at least anecdotally, many patients behind their screens are suffering from symptoms resembling angina and anginal equivalents but feel that they are not being given serious attention as patients and thus suffer additionally from a lack of diagnosis (which then equates to a lack of treatment). Clinicians are only just now realizing how prevalent ischemia without any obstructed coronary arteries (INOCA) really is, but clinical practice continues to lag far behind with only a handful of institutions offering the ability to interrogate the microvasculature to get a "complete" picture of patient heart health. Worse still, almost all of our traditional non-invasive frontline tests are notoriously difficult to use consistently for diagnosing CMD at the beginning of a patient's care journey. Hear directly from CMD patients on our testimonials page: https://lnkd.in/gYbKd_3R

Understanding Hypertrophic Cardiomyopathy (HCM) ❤️ Did you know? 1 in 500 people live with Hypertrophic Cardiomyopathy (HCM) – a condition that thickens the heart muscle, making it harder for the heart to pump blood. 🌡️ With symptoms like shortness of breath, chest pain, and fatigue, HCM can have a serious impact on daily life. Through Project ENACT – a partnership between The Mended Hearts, Inc. and WomenHeart: The National Coalition for Women with Heart Disease – we’re committed to making clinical trials more accessible, offering resources to help those affected by HCM find new treatment options. 🫀✨ 👉 Learn more in our Clinical Trials Discussion Guide – complete with key questions to ask and insights into why clinical trials matter for heart health! https://lnkd.in/eVggDS7 #ClinicalTrials #WomenHeart #ENACT #MendedHearts

🌟 Exploring Chronic Diseases: Medication adherence challenges and solutions 🌟 As healthcare professionals dedicated to improving patient outcomes, let’s embark on a weekly journey. We will delve into a different chronic disease, unraveling its unique challenges and exploring practical solutions. Why? Because addressing these challenges enhances patient-centered care and quality of life ツ our main goal ! This Week: Multiple Sclerosis (MS) Challenge: Cognitive Functions Did you know that half of people with MS experience changes in cognitive functions? These changes often affect memory, attention, and information processing. And guess what? These very functions play a pivotal role in treatment adherence. 🌟 Solutions: Enhancing Cognitive Function 1- Involving patient caregivers 🤝 * Educate caregivers about MS-related cognitive challenges. * Be the emotional support system- they will appreciate it. 2- Encourage patients to have healthy lifestyle. * By prioritizing nutrition, exercise, and quality sleep. 3- Cognitive Rehabilitation * Engaging in cognitive exercises to boost memory and problem-solving skills. Question 🌟 What strategies have you found most effective in supporting MS patients with cognitive deficits in their medication adherence? Share your insights! And remember, personalized strategies empower MS patients with cognitive deficits to manage their medications effectively. Here’s a patient quote to inspire us: “Navigating MS can be tough, but with the right support, we can stay on track!” — Sarah, MS Warrior 🌐💙 #MultipleSclerosis #CognitiveHealth #MedicationAdherence #PatientSupport #NeverStandStill #PatientsFirst

Surfactant is a miracle drug. Used in NICUs every day. It has saved countless newborns. Surfactant = surface active agent. It’s like soap. It lowers surface tension. We all make it, but the cells that make it in preterm infants are immature. When you give it you often see a fairly rapid decrease in oxygen requirement. It is a life saver. Check out this story.

Today marks a paradigm shift in the monitoring of #Type1diabetes (T1D). Our organisation, along with 60+ international experts & 10+ diabetes orgs, published new T1D monitoring guidance for health care professionals. Research has shown that the condition can exist without symptoms for months or years as early-stage T1D, before it is traditionally diagnosed. Until now, there was no standard advice on how to detect, follow up, or support people with early-stage T1D. For the first time, individuals, families, and healthcare professionals now have concrete guidance how to diagnose early-stage T1D, monitor progression of the condition, catch symptoms early to prevent diabetic ketoacidosis and identify those eligible for clinical trials. The guidance document was co-authored by JDRF-funded Australian researchers Jennifer Couper, Maria Craig, Kirstie Bell, John Wentworth and endorsed by the Australian Diabetes Society. Learn more on our website: https://jdrf.news/8i8 Breakthrough T1D, Charles Perkins Centre, University of Adelaide, The Royal Melbourne Hospital, WEHI (Walter and Eliza Hall Institute of Medical Research), UNSW Medicine & Health Anastasia Albanese-O'Neill, Sanjoy Dutta, Moshe Phillip, Linda DiMeglio

💉Here’s everything you need to know about GLP-1 RAs for your patients: https://bit.ly/4cNe7SC Are you or your patients curious about GLP-1 RAs like Ozempic for weight loss? Learn more about how GLP-1 RAs work, their benefits, and important safety considerations in our latest blog post. You’ll also get insights from Pamela Moye, PharmD, BCPS on the various facets of obesity management, from understanding the root causes and the epidemiological context to exploring the latest pharmacological interventions… and up to 2 hours of FREE CE! Get instant access here: https://bit.ly/4cNe7SC

💉Here’s everything you need to know about GLP-1 RAs for your patients: https://bit.ly/4cNe7SC Are you or your patients curious about GLP-1 RAs like Ozempic for weight loss? Learn more about how GLP-1 RAs work, their benefits, and important safety considerations in our latest blog post. You’ll also get insights from Pamela Moye, PharmD, BCPS on the various facets of obesity management, from understanding the root causes and the epidemiological context to exploring the latest pharmacological interventions… and up to 2 hours of FREE CE! Get instant access here: https://bit.ly/4cNe7SC

In German-speaking countries, we're transforming how women with fibroids access critical information and support: With our Starke Periode platform, we empower patients to better understand their symptoms and navigate their options for treatment. Our website and social media presence reach up to 17,000 users daily, providing trustworthy, medically-reviewed content about fibroid symptoms, causes, and innovative treatment options—ensuring women have the knowledge they need to make informed decisions. A major highlight of our platform is the Expert Panel, which includes medical professionals such as Mandy Mangler, Stefan Renner, Dr. Valentina Auletta, Prof. Thomas Römer, and Susanne Denny. These experts rigorously review our content, ensuring it's accurate and aligned with the latest medical research. We invite you to explore our educational resources and learn more about how Starke Periode is helping fibroid patients take control of their health: 🌐 www.starke-periode.de 📱 Social media: @starke.periode Ask your doctor if Sonata® may be right for you. Side effects may include bleeding, spotting, cramping, and/or discharge. For Safety Information or to learn more, visit https://lnkd.in/gQMnmC3q #FibroidAwareness #WomensHealth #PatientEducation #StarkePeriode